Photo taken from The ICR/X
Oct 9, 2024, 07:45
The ICR – Why at least half of patients fail to respond to Immunotherapy treatments
The ICR shared a post on X:
” We are delighted to be part of a new multimillion-pound research project – involving 16 institutions and 11 industry partners – aiming to discover why at least half of patients fail to respond to Immunotherapy treatments.”
Additional information.
Source: The ICR/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 15:37
Sep 7, 2025, 15:24
Sep 7, 2025, 14:57
Sep 7, 2025, 14:41
Sep 7, 2025, 14:23
Sep 7, 2025, 14:05